XILAPLUS® AF
Intended use
Contact us
XILAPLUS® AF:
The medical device is intended to restore the physiological functions of the intestinal walls, specifically formulated for the control and reduction of the symptoms related to diarrheal events of different aetiologies, such as abdominal tension and frequent emission of faeces.
The medical device acts by forming a film which protects the intestinal mucosa, reducing the frequency and duration of diarrhoea episodes.
CE 0476
Xilaplus® AF complies the Essential Requirements of Directive 93/42/EEC and subsequent amendments.
Composition
Powder for pediatric use without flavour: Xyloglucan, Gelose, Silicon Dioxide.
Tablets: Xyloglucan, Gelose, Cellulose, Magnesium Stearate (vegetable origin), Silicon Dioxide.
Capsules: Xyloglucan, Gelose, Magnesium Stearate (vegetable origin), Silicon Dioxide.
Download leaflet
XILAPLUS® AF around the world
Check it outFor more information, please
Contact usMagazine
Noventure will attend the 56th Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and…
The newer antidiarrheal agents include the mucoprotectants gelatin tannate and xyloglucan. Both were able to attenuat…
Noventure is proud to announce the launch of XILAPLUS® in Estonia, Latvia and Lithuania by our partner company Miecys…
